Bolt Biotherapeutics, Inc.

NASDAQ:BOLT

0.5824 (USD) • At close January 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -69.197-88.098-98.591-60.728-30.487-11.589
Depreciation & Amortization 1.8541.6661.1930.6110.3350.302
Deferred Income Tax 002.7620.03400
Stock Based Compensation 9.2239.5768.51.420.5080.123
Change In Working Capital -9.864-3.05720.507-2.2832.2651.139
Accounts Receivables 000000
Inventory 000000
Accounts Payables -3.4132.7686.6762.88200
Other Working Capital -6.451-5.82513.831-5.1652.2651.139
Other Non Cash Items -1.5413.4098.56313.6381.0360.153
Operating Cash Flow -69.525-76.504-57.066-47.308-26.343-9.872
Investing Activities:
Investments In Property Plant And Equipment -0.206-1.953-2.338-3.262-0.508-0.29
Acquisitions Net 0-59.815229.86317.3300
Purchases Of Investments -164.988-180.704-313.375-33.22900
Sales Maturities Of Investments 236.232240.51983.51215.89900
Other Investing Activites 059.815-229.863-17.3300
Investing Cash Flow 71.03857.862-232.201-20.592-0.508-0.29
Financing Activities:
Debt Repayment 0000-0.04-0.039
Common Stock Issued 0.2530.503259.2060.2940.0720.02
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0051.90239.30397.26238.246
Financing Cash Flow 0.2530.503311.10839.59748.62719.094
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 1.766-18.13921.841-28.30321.7768.932
Cash At End Of Period 12.57510.80928.9487.10735.4113.634